Search for a funded project
A TARGETED METABOMOLIC APPROACH TO DESIGN A PREDICTIVE MODEL FROM THE MONITORING OF THE INFLAMMATORY MEDIATORS KINETICS IN PATIENTS ADMITTED TO INTENSIVE CARE UNIT WITH COVID-19 PNEUMONIA. – COVID-METAFLAM
Beginning in December 2019, a novel coronavirus, designated SARS-CoV-2, has caused an international outbreak
a pandemic of a new emerging virus from the coronavirus family named COVID-19. Detection of infected
AiR mOnitoring high-riSk area: Air monitoring of coronaviruses (SARS-CoV2) presence in high-risk area – ARISE
recently occurring disease caused by the SARS-CoV-2 coronavirus. Its spreading is rapid and hard to control.
(PCR), which is the most common way to diagnose coronavirus.
An original public service between past and future: Public baths in France and Western Europe – THERMAPOLIS
several months by the health crisis of the « new coronavirus ». The research crosses an entry through public
and conformation spaces. Nanobodies targeting coronavirus antigens will be thus designed for specificity
Since 2003, three coronaviruses, SARS, MERS, and SARS-CoV-2, have led to devastating pandemics. Although [...] vaccines are available, new variants and even new coronaviruses could emerge at any time. Understanding the
CK2 inhibitors as chemobiological tools to unravel CK2 role in SARS-COV-2 lifecycle and as potential antivirals with broad-anti-coronavirus activity – CK2COV
rum antiviral activity against other human coronaviruses (HCoV-229E, OC43, NL63 and HKU1).
an acute respiratory disease caused by novel coronavirus SARS-CoV-2 also known as 2019-nCoV. On March
Endothelial damage and coagulation activation at the lung microvascular level may play an important role in the physiopathology of the COVID-19 ARDS. The project aims to prospectively investigate both bedside pulmonary physiological markers (mainly alveolar dead-space) and biological markers of coagulopathy and endothelial dysfunction in COVID-19 and non-COVID-19 ARDS patients.